Oncolytics Biotech Inc., a Canadian firm developing an intravenous immuno-oncolytic virus agent against various cancers, is on a transformational path it hopes will lead the 1998-founded business towards a future as a leading immuno-oncology biotech.
In 2017, Oncolytics appointed new leadership members to its executive team and switched up its R&D focus from non-small cell...








